Clinical assessment of memory impairment
90 results
1 - 90
Clinical assessment of memory impairment - Memory complaints, mild cognitive impairment and dementia
Patients with self-reported memory concerns more likely to develop cognitive impairment
Memory rehabilitation for people with multiple sclerosis- Screening tests for cognitive impairment not very accurate
- Pharmacological treatment for memory disorder in multiple sclerosis: Cochrane systematic review
- Pharmacotherapy for chronic cognitive impairment in traumatic brain injury: Cochrane systematic review
- Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment
- Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
- 11C‐PIB‐PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Psychosis in the elderly
- Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly: Cochrane systematic review
- Tool can identify early dementia, but to what end?
- Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting
- Piracetam for dementia or cognitive impairment: Cochrane systematic review
- Brief Memory and Executive Test is an effective screen for vascular dementia
- Cognitively enhanced tai chi improves cognition in adults with mild cognitive impairment
- Computerised cognitive training for preventing dementia in people with mild cognitive impairment
- Tai chi and cognition: limited quality evidence, small effect
- Lecithin for dementia and cognitive impairment: Cochrane systematic review
- Occupational therapy for cognitive impairment in stroke patients
- Vascular cognitive impairment (VCI)
- 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia
- Frontotemporal lobar degeneration
- Huperzine A for vascular dementia
- Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment
- Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias
- Clinical judgement by primary care physicians for the diagnosis of all‐cause dementia or cognitive impairment in symptomatic people
- Treatment for inhalant dependence and abuse: Cochrane systematic review
- 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Ginseng for cognition: Cochrane systematic review
- Mini‐Cog for the detection of dementia within a community setting
- 18F‐FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Diagnosis of epilepsy: definitions and workup
- Exergaming for dementia and mild cognitive impairment
- Choosing the place of care for an elderly patient with a long-term illness
- Hormone replacement therapy for cognitive function in postmenopausal women
- Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment
- Diagnostic test accuracy of self‐administered cognitive assessment tools for dementia
- Alzheimer’s disease
- Selegiline for Alzheimer's disease: Cochrane systematic review
- Insomnia
- Montreal Cognitive Assessment for the detection of dementia
- Galantamine for vascular cognitive impairment
- 18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Ginkgo biloba for cognitive impairment and dementia
- L‐carnitine for cognitive enhancement in people without cognitive impairment
- CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Acupuncture for vascular dementia
- Mini‐Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)
- Glycopyrrolate dries excessive salivation
- Rivastigmine for vascular cognitive impairment
- Interventions for childhood apraxia of speech
- Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people
- Aerobic exercise to improve cognitive function in older people without known cognitive impairment: Cochrane systematic review
- Antibiotic regimens for early‐onset neonatal sepsis
- Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife
- Addenbrooke’s Cognitive Examination III (ACE‐III) and mini‐ACE for the detection of dementia and mild cognitive impairment
- Electroconvulsive therapy for schizophrenia: Cochrane systematic review
- Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review
- Hormone replacement therapy for cognitive function in postmenopausal women
- Acetyl‐l‐carnitine for dementia
- Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
- Deep brain and cortical stimulation for epilepsy
- Metal protein attenuating compounds for the treatment of Alzheimer's dementia: Cochrane systematic review
- Acetylcholinesterase inhibitors for autistic spectrum disorders
- Obsessive-compulsive disorder (OCD) in children
- AD‐8 for detection of dementia across a variety of healthcare settings
- Systemic lupus erythematosus (SLE)
- Fractures of the spine
- Aspirin and other non‐steroidal anti‐inflammatory drugs for the prevention of dementia
- Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
- Music interventions for acquired brain injury